Claim 50% Off TipRanks Premium and Invest with Confidence
- Unlock hedge-fund level data and powerful investing tools designed to help you make smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis so your portfolio is always positioned for maximum potential
Towa Pharmaceutical Co ( (JP:4553) ) has shared an update.
Towa Pharmaceutical Co., Ltd. has revised its financial forecasts for the fiscal year ending March 31, 2025, reflecting a slight decrease in net sales and operating profit but a significant increase in ordinary profit and profit attributable to owners of the parent. The adjustments are attributed to foreign exchange gains, valuation of derivatives, and effective tax incentives, which have positively impacted the company’s financial outlook.
More about Towa Pharmaceutical Co
Towa Pharmaceutical Co., Ltd., headquartered in Kadoma, Osaka, is a company engaged in the pharmaceutical industry. It focuses on the development, production, and marketing of generic drugs, catering to a wide market that demands affordable medication options.
Average Trading Volume: 126,107
Technical Sentiment Signal: Hold
Current Market Cap: Yen129.8B
See more insights into 4553 stock on TipRanks’ Stock Analysis page.